Vasopharm’s ronopterin fails in traumatic brain injury trial
The trial’s primary and secondary endpoints enable analysis of the path of neurologic recovery in the first six months after…
Austria
Latest in
Austria
Apeiron Biologics gets regulatory approval for Phase II Covid-19 trial
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial…
Novo Nordisk’s somapacitan shows favourable profile in GHD trial
Novo Nordisk has reported positive data from the Phase II REAL 3 clinical trial of somapacitan in children with growth…
Computer simulation offers digital penicillin production
Researchers from Austrian university TU Wien and international pharmaceutical company Sandoz have developed a computer simulation that replicates the growth…